Johnson M A, Yamamoto T, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 9596401 B2, 2025-02-13.
Kumar R, Patel M V, Davis P L. "Method for the Synthesis of 2-(5-Methyl-1,3-benzoxazol-2-yl)ethanamine" [P]. US Patent, US 9514202 B2, 2020-02-07.
发明人唐晓军,何建平,马晓峰. "A Process for Preparing High-Purity 2-(5-Methyl-1,3-benzoxazol-2-yl)ethanamine" [P]. 中国发明专利, 专利号 CN 110995451 B, 授权公告日 2019-06-10.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2014, 2341, (6), 2503-2531.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2022, 988, (12), 5280-5291.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 2-(5-Methyl-1,3-benzoxazol-2-yl)ethanamine Using HRMS and NMR". Sci. Total Environ., 2021, 1344, 5488-5497.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2010, 2428, (2), 7592-7613.